Pulmonary artery catheterization and Carverdilol early initiation in cardiogenic shock casued by heart failure with reduced ejection fraction

Asan Medical Center0 个研究点目标入组 160 人开始时间: 待定最近更新: 2023年8月21日

适应症

试验速览

暂无简介。

•1) Adults age 19 and above ( no age limit for elderly )
•2) Patients with cardiogenic shock requiring intensive care monitoring in ICU
•3) Patients elegible for oral medication administration
•4) Patients who have provided research participation consent through a written informed consent form

•1) Unwilling or unable to obtain informed consent by the participant or substitute decision maker
•2) Patients with acute coronary syndrome
•3) Patients with severe valvular heart disease requiring emergent percutaneous procedures or surgery
•4) Known hypersensitivity to beta-blockers
•5) Patients with a history of bronchospasm or asthma
•6) Patients with bradycardia or second or third-degree atrioventricular block
•7) Patients with sick sinus syndrome, including sinoatrial block
•8) Patients with untreated pheochromocytoma
•9) Patients currently undergoing de-sensitization therapy
•10) Patients who are currently pregnant, postpartum period within 30 days or breast-feeding

发起方